Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-04-18

Clinical Trial Update: SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing aspirin versus standard of care for VTE prophylaxis after IBD surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Stefan Holubar MD MS FACS, FASCRS | Conditions: Crohn Disease, Ulcerative Colitis | Phase 3 | Status: WITHDRAWN